全球腸外營養市場規模、佔有率和成長分析：按營養類型、按階段類型、按症狀、按銷售管道、按地區 - 產業預測（2024-2031）

Parenteral Nutrition Market Size, Share, Growth Analysis, By Nutrition Type, By Stage Type, By Indication, By Sales Channel, By Region - Industry Forecast 2024-2031

出版日期: 2024年12月20日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球腸外營養市場規模將為67億美元，從2023年的71億美元成長到2031年的114億美元，預計在預測期內（2024-2031年）複合年成長率為6.0%。

由於面臨營養不良風險的老年人口的擴大，以及癌症和胃腸道疾病等慢性疾病的增加，預計全球腸外營養市場將繼續成長。腸外營養製劑的最新進展，包括提供可客製化營養組合的多室袋，改善了患者護理並簡化了給藥。然而，該市場面臨一些挑戰，例如與長期治療相關的感染風險、產品和設備的高成本以及限制可及性的監管障礙，特別是在新興地區。嚴格的感染控制措施、專業化生產和標準化指南的需求使市場動態變得複雜。總體而言，創新產品開發和監管協調對於應對這些挑戰和支持市場擴張至關重要。

B. Braun Melsungen AG
Fresenius Kabi AG
Sichuan Kelun Industrial Group Co Ltd
Pfizer Inc.
Baxter International Inc.
Grifols SA
Otsuka Holdings Co. Ltd（Otsuka Pharmaceutical Co., Ltd.）
Nirma Group（Aculife Healthcare Pvt. Ltd.）
Abbott Laboratories
Medtronic
Beximco Pharmaceuticals Ltd.
Sichuan Luye Pharmaceutical Co., Ltd.
ICU Medical, Inc.
JW Pharmaceutical Corporation
Servona GmbH
Anhui Medipharm Co., Ltd.
Nipro Corporation
Biosyn Arzneimittel
Terumo Corporation
Lonza Group

結論和建議

簡介目錄

Product Code: SQMIG35C2022

Global Parenteral Nutrition Market size was valued at USD 6.7 billion in 2022 and is poised to grow from USD 7.1 billion in 2023 to USD 11.4 billion by 2031, growing at a CAGR of 6.0% during the forecast period (2024-2031).

The global parenteral nutrition market is poised for continued growth, driven by rising chronic diseases such as cancer and gastrointestinal disorders, alongside an increasing geriatric population at risk of malnutrition. Recent advancements in parenteral nutrition formulations, including multi-chamber bags that offer customizable nutrient combinations, have enhanced patient care and ease of administration. However, the market faces challenges like infection risks associated with long-term therapy, high costs of products and equipment, and regulatory hurdles that can limit accessibility, especially in developing regions. The need for stringent infection control measures, specialized manufacturing, and standardized guidelines complicates market dynamics. Overall, innovative product development and harmonized regulations will be crucial for addressing these challenges and supporting market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Parenteral Nutrition market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Parenteral Nutrition Market Segmental Analysis

Global Parenteral Nutrition Market is segmented by Nutrition Type, Stage Type, Indication, Sales Channel and region. Based on Nutrition Type, the market is segmented into Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins & Minerals. Based on Stage Type, the market is segmented into Adult, Pediatrics. Based on Indication, the market is segmented into Alzheimer's, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Disease, Orphan Diseases, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, Others. Based on Sales Channel, the market is segmented into Online, Retail, and Institutional. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Parenteral Nutrition Market

The global market for parenteral nutrition is significantly driven by technological advancements in product formulations and delivery systems. Innovations in nutrient combinations and formulation techniques have markedly improved the safety and effectiveness of parenteral nutrition therapies. These enhancements not only streamline the administration process for healthcare providers but also increase comfort and tolerance for patients undergoing treatment. As a result, the upgraded products and methods are expanding the reach and application of parenteral nutrition, reinforcing its vital role in supporting patients who cannot receive adequate nutrition through traditional means. Such developments are crucial in meeting the growing demand for specialized nutritional care on a global scale.

Restraints in the Global Parenteral Nutrition Market

The global parenteral nutrition market faces significant restraints, primarily due to regulatory constraints and the absence of standardized protocols. Divergent regulations and inconsistent guidelines for parenteral nutrition therapy in various regions create hurdles for both manufacturers and healthcare professionals. This lack of uniformity can lead to complications in ensuring the safe and effective delivery of parenteral nutrition. To overcome these challenges, it is crucial to establish harmonized regulatory frameworks and develop evidence-based guidelines that can foster consistency and enhance patient care across different geographic locations. Addressing these issues is vital for the growth and stability of the market.

Market Trends of the Global Parenteral Nutrition Market

The Global Parenteral Nutrition market is witnessing a significant trend toward the integration of digital health technologies, including mobile applications, connected devices, and telehealth solutions. This shift facilitates remote monitoring and real-time data collection, which enhances communication between patients, caregivers, and healthcare providers. As a result, healthcare professionals can better manage parenteral nutrition therapy, leading to improved treatment outcomes and patient satisfaction. The increasing focus on personalized medicine and the rising demand for remote healthcare solutions are driving this trend, indicating a robust growth trajectory for the market as technology plays an essential role in optimizing nutritional support.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Value Chain Analysis
Patent Analysis
PESTEL Analysis
Macro-Economic Indicators
Market Attractiveness Index

Global Parenteral Nutrition Market Size by Nutrition Type & CAGR (2024-2031)

Market Overview
Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Trace Elements
Vitamins & Minerals

Global Parenteral Nutrition Market Size by Stage Type & CAGR (2024-2031)

Market Overview
Adult
Pediatrics

Global Parenteral Nutrition Market Size by Indication & CAGR (2024-2031)

Market Overview
Alzheimer's
Nutrition Deficiency
Cancer Care
Diabetes
Chronic Kidney Diseases
Orphan Diseases
Dysphagia
Pain Management
Malabsorption/GI Disorder/Diarrhea
Others

Global Parenteral Nutrition Market Size by Sales Channel & CAGR (2024-2031)

Market Overview
Online
Retail
Institutional

Global Parenteral Nutrition Market Size & CAGR (2024-2031)

North America (Nutrition Type, Stage Type, Indication, Sales Channel)
- US
- Canada
Europe (Nutrition Type, Stage Type, Indication, Sales Channel)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific (Nutrition Type, Stage Type, Indication, Sales Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America (Nutrition Type, Stage Type, Indication, Sales Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Nutrition Type, Stage Type, Indication, Sales Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

B. Braun Melsungen AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Kabi AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sichuan Kelun Industrial Group Co Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Otsuka Holdings Co. Ltd (Otsuka Pharmaceutical Co., Ltd.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nirma Group (Aculife Healthcare Pvt. Ltd.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beximco Pharmaceuticals Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sichuan Luye Pharmaceutical Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICU Medical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JW Pharmaceutical Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Servona GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anhui Medipharm Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biosyn Arzneimittel
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments